Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lannett Company Inc (LCI)

Lannett Company Inc (LCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,381
  • Shares Outstanding, K 10,767
  • Annual Sales, $ 340,580 K
  • Annual Income, $ -231,620 K
  • 60-Month Beta 0.95
  • Price/Sales 0.02
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LCI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.44
  • Most Recent Earnings $-1.36 on 02/01/23
  • Latest Earnings Date 05/03/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 202.78%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -1.56
  • Number of Estimates 2
  • High Estimate -1.56
  • Low Estimate -1.56
  • Prior Year -1.64
  • Growth Rate Est. (year over year) +4.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6375 +7.53%
on 04/14/23
1.8900 -63.73%
on 04/03/23
-0.9645 (-58.45%)
since 03/17/23
3-Month
0.6375 +7.53%
on 04/14/23
3.2500 -78.91%
on 02/07/23
-1.8325 (-72.78%)
since 01/19/23
52-Week
0.6375 +7.53%
on 04/14/23
3.7200 -81.57%
on 12/21/22
-2.1697 (-75.99%)
since 04/19/22

Most Recent Stories

More News
LANNETT SHARES UPDATE

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) (the "Company") today shared a business update as it focuses on strategically positioning the Company to...

LCI : 0.6855 (+3.86%)
Lannett (LCI) Reports Q2 Loss, Tops Revenue Estimates

Lannett (LCI) delivered earnings and revenue surprises of 17.07% and 10.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LCI : 0.6855 (+3.86%)
RLAY : 7.50 (-5.66%)
LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE

Q2 Business and Financial Highlights: Net Sales were $80.9 Million Gross Margin was 18%, Adjusted Gross Margin was 19% Net Sales, Gross Margin and Adjusted...

LCI : 0.6855 (+3.86%)
LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLIT

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that its Board of Directors approved a 1-for-4 reverse stock split of its issued and...

LCI : 0.6855 (+3.86%)
LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2023 second quarter on Wednesday,...

LCI : 0.6855 (+3.86%)
LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today provided an update on the clinical advancement and development of its biosimilar insulin aspart and...

LCI : 0.6855 (+3.86%)
LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the...

LCI : 0.6855 (+3.86%)
Lannett (LCI) Reports Q1 Loss, Tops Revenue Estimates

Lannett (LCI) delivered earnings and revenue surprises of 8.70% and 10.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LCI : 0.6855 (+3.86%)
XERS : 2.13 (-4.48%)
LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2023 first quarter on Wednesday,...

LCI : 0.6855 (+3.86%)
LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANT

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the US Food and Drug Administration (FDA) to manufacture...

LCI : 0.6855 (+3.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable...

See More

Key Turning Points

3rd Resistance Point 0.7897
2nd Resistance Point 0.7546
1st Resistance Point 0.7201
Last Price 0.6855
1st Support Level 0.6505
2nd Support Level 0.6154
3rd Support Level 0.5809

See More

52-Week High 3.7200
Fibonacci 61.8% 2.5425
Fibonacci 50% 2.1788
Fibonacci 38.2% 1.8150
Last Price 0.6855
52-Week Low 0.6375

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar